June 20, 2017 / 10:20 AM / a month ago

BRIEF-Akcea Therapeutics sees IPO price to be between $12-$14/shr

1 Min Read

June 20 (Reuters) - Akcea Therapeutics Inc:

* Sees IPO of 9.62 million shares of common stock - SEC filing

* Akcea Therapeutics Inc says initial public offering price expected to be between $12.00 and $14.00 per share

* Akcea Therapeutics Inc says intends to use about $80.0 million of IPO proceeds to complete planned Phase 3 development for Volanesorsen in both FCS and FPL

* Akcea Therapeutics Inc says intends to use about $30.0 million of IPO proceeds to complete planned Phase 2 program for Akcea-APO(A)-LRX

* Akcea Therapeutics Inc says intends to use about $16.0 million of IPO proceeds to complete the planned Phase 2 program for Akcea-ANGPTL3-LRX Source text: (bit.ly/2tnlFG9)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below